4//SEC Filing
Hulse William Frank IV 4
Accession 0001376339-25-000027
CIK 0001376339other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:56 PM ET
Size
6.9 KB
Accession
0001376339-25-000027
Insider Transaction Report
Form 4
Hulse William Frank IV
General Counsel and CAO
Transactions
- Sale
Common Stock
2025-03-10$7.80/sh−81,446$635,279→ 494,774 total
Holdings
- 108,432
Stock Options
Exercise: $8.30Exp: 2032-03-03→ Common Stock (108,432 underlying)
Footnotes (3)
- [F1]The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $7.74 to $7.96, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The exercise price of the Stock Options awarded on March 3, 2025 as stated in the Reporting Person's Form 4 filed March 5, 2025 inadvertently included a typographical error. This Form 4 accurately states the exercise price for the Stock Options awarded to the Reporting Person on March 3, 3025.
- [F3]The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..
Documents
Issuer
MIMEDX GROUP, INC.
CIK 0001376339
Entity typeother
Related Parties
1- filerCIK 0001796044
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:56 PM ET
- Size
- 6.9 KB